相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Recent advances in HER2-targeted delivery for cancer therapy
Rakesh Kumar Dhritlahre et al.
DRUG DISCOVERY TODAY (2021)
Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer
Navid Sobhani et al.
CELLS (2021)
HER2-targeted therapies - a role beyond breast cancer
Do-Youn Oh et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Peruvoside targets apoptosis and autophagy through MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human cancers
Dhanasekhar Reddy et al.
LIFE SCIENCES (2020)
The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer
Lei Zhang et al.
MOLECULAR CANCER (2020)
DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer
Eva Galle et al.
CLINICAL EPIGENETICS (2020)
Inhibition of mitochondria ATP synthase suppresses prostate cancer growth through reduced insulin-like growth factor-1 secretion by prostate stromal cells
Tomokazu Ohishi et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments
Navid Sobhani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Promises of Fibroblast Growth Factor Receptor-Directed Therapy in Tailored Cancer Treatment
Sharmila Fagoonee et al.
JOURNAL OF CLINICAL MEDICINE (2020)
c-Src and EGFR Inhibition in Molecular Cancer Therapy: What Else Can We Improve?
Stefania Belli et al.
CANCERS (2020)
Src Family Kinases as Therapeutic Targets in Advanced Solid Tumors: What We Have Learned So Far
Stefano Martellucci et al.
CANCERS (2020)
Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy
Hui Hua et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?
Luca Braglia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
Downregulation of the let-7 family of microRNAs may promote insulin receptor/insulin-like growth factor signalling pathways in pancreatic ductal adenocarcinoma
Ekene Emmanuel Nweke et al.
ONCOLOGY LETTERS (2020)
The FGF/FGFR System in Breast Cancer: Oncogenic Features and Therapeutic Perspectives
Maria Francesca Santolla et al.
CANCERS (2020)
Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy
Yu Kanemaru et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development
Juan Huang et al.
FRONTIERS IN ONCOLOGY (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
The growing role of precision and personalized medicine for cancer treatment
Paulina Krzyszczyk et al.
TECHNOLOGY (2018)
Carbonic Anhydrases: Role in pH Control and Cancer
Mam Y. Mboge et al.
METABOLITES (2018)
The Role of Next-Generation Sequencing in Precision Medicine: A Review of Outcomes in Oncology
Margaret Morash et al.
JOURNAL OF PERSONALIZED MEDICINE (2018)
Precision medicine in breast cancer
Yoichi Naito et al.
CHINESE CLINICAL ONCOLOGY (2018)
Chemoresistance and targeted therapies in ovarian and endometrial cancers
Kevin Brasseur et al.
ONCOTARGET (2017)
What is precision medicine?
Inke R. Koenig et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Cancer Precision Medicine: Why More Is More and DNA Is Not Enough
Moritz Schuette et al.
PUBLIC HEALTH GENOMICS (2017)
Combination therapy in combating cancer
Reza Bayat Mokhtari et al.
ONCOTARGET (2017)
Bevacizumab Plus Radiosurgery for Nonsquamous Non-Small Cell Lung Cancer Patients with Brain Metastases: Safe Combination?
Julien Guinde et al.
WORLD NEUROSURGERY (2017)
Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine
Krysta Mila Coyle et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Precision medicine driven by cancer systems biology
Fabian V. Filipp
CANCER AND METASTASIS REVIEWS (2017)
Building towards precision medicine: empowering medical professionals for the next revolution
Scott McGrath et al.
BMC MEDICAL GENOMICS (2016)
Combination therapy targeting both cancer stem-like cells and bulk tumor cells for improved efficacy of breast cancer treatment
Tao Wang et al.
CANCER BIOLOGY & THERAPY (2016)
Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives
Li Zhou et al.
EXPERT REVIEW OF PROTEOMICS (2016)
Omics Profiling in Precision Oncology
Kun-Hsing Yu et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Building the foundation for genomics in precision medicine
Samuel J. Aronson et al.
NATURE (2015)
Real-time metabolome profiling of the metabolic switch between starvation and growth
Hannes Link et al.
NATURE METHODS (2015)
Precision medicine for metastatic breast cancer-limitations and solutions
Monica Arnedos et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Lapatinib sensitizes quiescent MDA-MB-231 breast cancer cells to doxorubicin by inhibiting the expression of multidrug resistance-associated protein-1
Yun-Suk Kwon et al.
ONCOLOGY REPORTS (2015)
Diagnostic and prognostic epigenetic biomarkers in cancer
Pedro Costa-Pinheiro et al.
EPIGENOMICS (2015)
Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including Acetazolamide in human Glioblastoma
Harun M. Said et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
IDH1 and IDH2 Mutations in Gliomas
Adam L. Cohen et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2013)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Trastuzumab emtansine in human epidermal growth factor receptor 2-positive breast cancer: a review
Jacob Mathew et al.
CURRENT OPINION IN ONCOLOGY (2011)
Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies
Jin Li et al.
BMC CANCER (2010)
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Gideon Bollag et al.
NATURE (2010)
Targeted cancer therapies
Saurabh Aggarwal
NATURE REVIEWS DRUG DISCOVERY (2010)
METLIN - A metabolite mass spectral database
CA Smith et al.
THERAPEUTIC DRUG MONITORING (2005)
Development of the proteasome inhihitor Veleade((TM)) (Bortezomib)
J Adams et al.
CANCER INVESTIGATION (2004)
Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs
MV Blagosklonny et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
